Neuronal differentiation in human neuroblastoma cells by nerve growth factor following TrkA up-regulation by interferon-γ

Medical and Pediatric Oncology

Volumn 34, Issue 6, 2000, Pages 394-401

  Shikata, Akane ^a,c   Shikata, Takuma ^a   Sotozono, Yasuhiro ^a   Hosoi, Hajime ^a   Matsumura, Takafumi ^a   Sugimoto, Tohru ^b   Sawada, Tadashi ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c NONE   (Japan)

Author keywords

Differentiation; IFN ; Neuroblastoma; NGF; TrkA

Indexed keywords

GAMMA INTERFERON; NERVE GROWTH FACTOR; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENZYME INDUCTION; GROWTH STIMULATION; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; INTERFERON TYPE II; NERVE GROWTH FACTOR; NEUROBLASTOMA; PHOSPHORYLATION; PRECIPITIN TESTS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, TRKA; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TYROSINE; UP-REGULATION;

EID: 0034045120     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(200006)34:6<394::AID-MPO3>3.0.CO;2-5     Document Type: Article

References (43)

1. Brodeur GM. Neuroblastoma: clinical significance of genetic abnormalities. Cancer Surv 1990;9:673-688.
2. Evans AE, Gerson J, Schnaufer L. Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr 1976;44:49-54.
3. Martin-Zanca D, Oskam R, Mitra G, et al. Molecular and biochemical characterization of the human trk proto-oncogene. Mol Cell Biol 1989;9:24-33.
4. Kaplan DR, Hempstead BL, Martin-Zanca D, et al. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 1991;252:554-558.
5. Klein R, Jing S, Nanduri V, et al. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 1991;65:189-197.
6. Klein R, Parada LF, Coulier F, Barbacid M. trkB, a novel tyrosine protein kinase receptor expressed during mouse neuronal development. EMBO J 1989;8:3701-3709.
7. Lamballe F, Klein R, Barbacid M. trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell 1991;66:967-979.
8. Ip NY, Stitt TN, Tapley P, et al. Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells. Neuron 1993;10:137-149.
9. Martin-Zanca D, Barbacid M, Parada LF. Expression of the trk proto-oncogene is restricted to the sensory cranial and spinal ganglia of neural crest origin in mouse development. Genes Dev 1990;4:683-694.
10. Nakagawara A, Arima M, Azar CG, et al. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res 1992;52:1364-1368.
11. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, et al. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 1993; 328:847-854.
12. Suzuki T, Bogenmann E, Shimada H, et al. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. JNCI 1993;85:377-384.
13. Borrello MG, Bongarzone I, Pierotti MA, et al. trk And ret proto-oncogene expression in human neuroblastoma specimens: high-frequency of trk expression in non-advanced stages. Int J Cancer 1993;54:540-545.
14. Kogner P, Barbany G, Björk O, et al. TRK mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors. Adv Neuroblastoma Res 1994;4:137-145.
15. Azar CG, Scavarda NJ, Reynolds CP, Brodeur GM. Multiple defects of the nerve growth factor receptor in human neuroblastomas. Cell Growth Differ 1990;1:421-428.
16. Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM. Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 1994;14:759-767.
17. Shikata A, Sugimoto T, Hosoi H, et al. Increased expression of trk proto-oncogene by γ-interferon in human neuroblastoma cell lines. Jpn J Cancer Res 1994;85:122-126.
18. Sugimoto T, Sawada T, Matsumura T, et al. Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient. Cancer Res 1986;46:4765-4769.
19. Tumilowicz JJ, Nichols WW, Cholon JJ, Greene AE. Definition of a continuous human cell line derived from neuroblastoma. Cancer Res 1970;30:2110-2118.
20. Miyake S, Shimo Y, Kitamura T, et al. Characteristics of continuous and functional cell line NB-1, derived from a human neuroblastoma. Auton Nerve Syst 1973;10:115-120.
21. Biedler JL, Helson L, Spengler BA. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 1973;33:2643-2652.
22. Matsumura T, Sugimoto T, Sawada T, et al. Cell surface membrane antigen present on neuroblastoma cells but not fetal neuroblasts recognized by a monoclonal antibody (KP-NAC8). Cancer Res 1987;47:2924-2930.
23. Broduer GM, Green AA, Hayes FA, et al. Cytogenetic features of human neuroblastomas and cell lines. Cancer Res 1981;41:4678-4686.
24. Katoh-Senba R, Kitajima S, Yamazaki Y, Sano M. Neuritic growth from a new subline of PC12 pheochromocytoma cells: cyclic AMP mimics the action of nerve growth factor. J Neurosci Res 1987;17:36-44.
25. Kaufman RJ, Sharp PA. Construction of a modular dihydrofolate reductase cDNA gene: analysis of signals utilized for efficient expression. Mol Cell Biol 1982;2:1304-1319.
26. Meakin SO, Suter U, Drinkwater CC, et al. The rat trk protoon-cogene product exhibits properties characteristic of the slow nerve growth factor receptor. Proc Natl Acad Sci USA 1992;89:2374-2378.
27. Schwab M, Alitalo K, Klempnauer K-H, et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 1983;305:245-248.
28. Chao MV, Bothwell MA, Ross AH, et al. Gene transfer and molecular cloning of the human NGF receptor. Science 1986;232: 518-521.
29. Myers MW, Lazzarini RA, Lee VM-Y, et al. The human mid-size neurofilament subunit: a repeated protein sequence and the relationship of its gene to the intermediate filament gene family. EMBO J 1987;6:1617-1626.
30. Minty AJ, Alonso S, Guenet J-L, Buckingham ME. Number and organization of actin-related sequences in the mouse genome. J Mol Biol 1983;167:77-101.
31. Harada H, Kitagawa M, Tanaka N, et al. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 1993;259:971-974.
32. Brysk MM, Bell T, Hoida C, et al. Interferon-γ modulates terminal differentiation and the expression of desquamin in cultured keratinocytes. Exp Cell Res 1991;197:140-147.
33. Wuarin L, Verity MA, Sidell N. Effects of interferon-gamma and its interaction with retinoic acid on human neuroblastoma differentiation. Int J Cancer 1991;48:136-141.
34. Lucarelli E, Kaplan DR, Thiele CJ. Selective regulation of TrkA and TrkB receptors by retinoic acid and interferon-γ in human neuroblastoma cell lines. J Biol Chem 1995;270:24725-24731.
35. Gross N, Beck D, Farve S. In vitro modulation and relationship between N-myc and HLA class I RNA steady-state levels in human neuroblastoma cells. Cancer Res 1990;50:7532-7536.
36. Matsushima H, Bogenmann E. Expression of trkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo. Mol Cell Biol 1993;13:7447-7456.
37. NGFR-associated protein kinase. EMBO J 1996;15:3369-3376.
38. Ross AH, Daou M-C, Mckinnon CA, et al. The neurotrophin receptor, gp75, forms a complex with the receptor tyrosine kinase TrkA. J Cell Biol 1996;132:945-953.
39. Chao MV, Hempstead BL. p75 and Trk: a two-receptor system. Trends Neurosci 1995;18:321-326.
40. Vetter ML, Martin-Zanca D, Parada LF, et al. Nerve growth factor rapidly stimulates tyrosine phosphorylation of phospholipase C-γ1 by a kinase activity associated with the product of the trk protooncogene. Proc Natl Acad Sci USA 1991;88:5650-5654.
41. Ohmichi M, Decker SJ, Saltiel AR. Activation of phosphatidylinositol-3 kinase by nerve growth factor involves indirect coupling of the trk proto-oncogene with src homology 2 domains. Neuron 1992;9:769-777.
42. Sadowski HB, Shuai K, Darnell JE Jr, Gilman MZ. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 1993;261:1739-1744.
43. Xia Z, Dickens M, Raingeaud J, et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326-1331.